Sign Up to like & get
recommendations!
1
Published in 2017 at "Brain and Behavior"
DOI: 10.1002/brb3.644
Abstract: Multiple sclerosis (MS) patients treated with interferon beta (IFNβ) are at risk of a declining response to treatment because of the production of IFNβ‐neutralizing antibodies (NAbs). The expression of Myxovirus resistance protein A (MxA) mRNA…
read more here.
Keywords:
preceding nab;
mxa mrna;
ifn;
decrease preceding ... See more keywords